再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

未开盘 12-20 16:08:10

20.600

+0.300

+1.48%

最高20.850	最低20.200	成交量266.95万
今开20.300	昨收20.300	日振幅3.20%
总市值225.36亿	流通市值225.36亿	总股本10.94亿
成交额5,504万	换手率0.24%	流通股本10.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":20.6,"timestamp":1734682090021,"preClose":20.3,"halted":0,"volume":2669502,"delay":0,"floatShares":1094000000,"shares":1094000000,"eps":-2.692127,"marketStatus":"未开盘","marketStatusCode":0,"change":0.3,"latestTime":"12-20 16:08:10","open":20.3,"high":20.85,"low":20.2,"amount":55044594,"amplitude":0.03202,"askPrice":20.6,"askSize":17300,"bidPrice":20.55,"bidSize":89600,"shortable":3,"etf":0,"ttmEps":-2.1591534621903623,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"listingDate":1601222400000,"adjPreClose":20.3,"openAndCloseTimeList":[[1734658200000,1734667200000],[1734670800000,1734681600000]],"volumeRatio":1.4222675301146286,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688","defaultTab":"news","newsList":[{"id":"2493287994","title":"再鼎医药上涨2.21%，报26.8美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493287994","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493287994?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:45","pubTimestamp":1734709533,"startTime":"0","endTime":"0","summary":"12月20日，再鼎医药(ZLAB)盘中上涨2.21%，截至23:45，报26.8美元/股，成交221.93万美元。财务数据显示，截至2024年09月30日，再鼎医药收入总额2.9亿美元，同比增长44.32%；归母净利润-1.75亿美元，同比增长26.66%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/20234546667606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU2488822045.USD","ZLAB","BK4139","09688","BK1161","BK4531","BK4526","BK4588","BK1588","BK4585","BK1574","BK4548"],"gpt_icon":0},{"id":"2492049212","title":"再鼎医药12月20日主力资金流入61万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492049212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492049212?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:15","pubTimestamp":1734682537,"startTime":"0","endTime":"0","summary":"12月20日, 再鼎医药股价涨1.48%，报收20.60元，成交金额5504万元，换手率0.24%，振幅3.20%，量比1.42。再鼎医药今日主力资金净流入61万元，连续7日净流入，上一交易日主力净流入119万元，今日环比减少48.74%。近一年数据显示，该股主力连续7日净流入后，次日上涨概率为12.50%，平均涨幅为0.64%。该股近5个交易日上涨0.73%，主力资金累计净流入458万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入733万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220161629ab866c41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220161629ab866c41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","LU2488822045.USD","BK1588","BK1574"],"gpt_icon":0},{"id":"2492583911","title":"再鼎医药下跌2.19%，报26.38美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492583911","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492583911?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:16","pubTimestamp":1734549411,"startTime":"0","endTime":"0","summary":"12月19日，再鼎医药(ZLAB)盘中下跌2.19%，截至03:16，报26.38美元/股，成交745.72万美元。财务数据显示，截至2024年09月30日，再鼎医药收入总额2.9亿美元，同比增长44.32%；归母净利润-1.75亿美元，同比增长26.66%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/19031646565917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4548","BK4531","BK4585","09688","BK1161","BK1588","BK1574","ZLAB","BK4139","BK4526","LU2488822045.USD","BK4588"],"gpt_icon":0},{"id":"2492979218","title":"再鼎医药12月18日主力资金流入134万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492979218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492979218?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:15","pubTimestamp":1734509746,"startTime":"0","endTime":"0","summary":"12月18日, 再鼎医药股价涨4.41%，报收21.30元，成交金额3249万元，换手率0.14%，振幅4.17%，量比0.84。再鼎医药今日主力资金净流入134万元，连续5日净流入，上一交易日主力净流入35万元，今日环比增加282.86%。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为38.46%，平均涨幅为4.55%。该股近5个交易日下跌1.15%，主力资金累计净流入387万元；近20日主力资金累计净流入3302万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218161607ab81475e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218161607ab81475e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1161","LU2488822045.USD","BK1588","BK1574"],"gpt_icon":0},{"id":"2492973452","title":"港股生物技术板块尾盘走强，歌礼制药(01672.HK)涨超15%，圣诺医药(02257.HK)涨超9%，再鼎医药(09688.","url":"https://stock-news.laohu8.com/highlight/detail?id=2492973452","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492973452?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:31","pubTimestamp":1734507119,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["02197","01672","09688","HSTECH","BK1515","01477","YANG","BK4588","02257","BK4139","BK1588","BK4526","BK1191","07226","LU2488822045.USD","BK4585","BK4548","HSCEI","ZLAB","BK4531","BK1161","BK1574"],"gpt_icon":0},{"id":"2492941582","title":"创新药概念多数上扬 圣诺医药(02257)涨11.56% 机构指医药创新是医药增长的核心动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2492941582","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492941582?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:55","pubTimestamp":1734486946,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念多数上扬，圣诺医药 涨11.56%，百奥赛图涨9.68%，歌礼制药涨7.98%，绿竹生物涨4.73%，再鼎医药涨4.41%，康诺亚涨1.34%，中国生物制药涨0.95%，信达生物涨0.69%银河证券表示，1）医药创新是医药增长的核心动力。对于医药板块， 在“医保+商保”模式不断推进、政策支持等因素驱动下，行业规模有望进一步扩大。“医保+商保”模式打开健康险空间，创新药发展空间更大。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949850","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1583","LU1969619763.USD","BK1587","159938","01177","02257","BK1161","LU2328871848.SGD","01801","02162","BK1589","09688","02315","BK1191","06978","BK1521","BK1574","09939","01672","LU2488822045.USD","BK1588","BK1515","02480"],"gpt_icon":0},{"id":"2492368941","title":"再鼎医药(09688)上涨5.15%，报21.45元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492368941","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492368941?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:43","pubTimestamp":1734486189,"startTime":"0","endTime":"0","summary":"12月18日，再鼎医药(09688)盘中上涨5.15%，截至09:43，报21.45元/股，成交605.45万元。再鼎医药有限公司主要业务是研发和销售针对肿瘤、自身免疫性疾病、感染性疾病和中枢神经系统疾病的创新药物，以满足全球患者的医疗需求。关键经营数据方面，公司以其强大的研发能力和全球化运营策略，致力于成为全球领先的生物制药公司。截至2024年三季报，再鼎医药营业总收入20.32亿元、净利润-12.29亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/18094346520900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4548","BK4531","BK4585","09688","BK1161","BK1588","BK1574","ZLAB","BK4139","BK4526","LU2488822045.USD","BK4588"],"gpt_icon":0},{"id":"2492414879","title":"再鼎医药盘中异动 早盘股价大涨5.15%报21.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414879?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:43","pubTimestamp":1734486188,"startTime":"0","endTime":"0","summary":"2024年12月18日早盘09时43分，再鼎医药股票出现波动，股价急速上涨5.15%。截至发稿，该股报21.450港元/股，成交量28.61万股，换手率0.03%，振幅4.17%。资金方面，该股资金流入368.688万港元，流出195.808万港元。再鼎医药股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，百奥赛图-B、圣诺医药-B、帝王国际投资涨幅较大，振幅较大的相关个股有永泰生物-B、基石药业-B、晶泰控股-P，振幅分别为14.23%、6.74%、6.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218094308a1f73713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218094308a1f73713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1588","LU2488822045.USD","BK1574","09688"],"gpt_icon":0},{"id":"2492096710","title":"再鼎医药上涨2.1%，报26.73美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492096710","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492096710?lang=zh_cn&edition=full","pubTime":"2024-12-18 00:27","pubTimestamp":1734452866,"startTime":"0","endTime":"0","summary":"12月18日，再鼎医药(ZLAB)盘中上涨2.1%，截至00:27，报26.73美元/股，成交264.77万美元。财务数据显示，截至2024年09月30日，再鼎医药收入总额2.9亿美元，同比增长44.32%；归母净利润-1.75亿美元，同比增长26.66%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/18002746507473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["ZLAB","BK1161","BK4531","BK1588","BK4588","BK4548","LU2488822045.USD","BK1574","09688","BK4526","BK4139","BK4585"],"gpt_icon":0},{"id":"2492934870","title":"再鼎医药(09688)发行800万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492934870","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492934870?lang=zh_cn&edition=full","pubTime":"2024-12-17 18:18","pubTimestamp":1734430708,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，于2024年12月17日，该公司发行800万股新普通股，由受托人持有，以兑现按先前披露的条款归属及(如适用)行使(1)根据2015，2017及2022年股权激励计划所授出的购股权及(2)根据2017和2022年股权激励计划所授出的非期权奖励。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4139","BK4585","LU2488822045.USD","BK1574","BK4531","BK4588","BK4548","BK1161","09688","BK4526","BK1588","ZLAB"],"gpt_icon":0},{"id":"2491651413","title":"再鼎医药12月16日获主力加仓106万元 环比增加523.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491651413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491651413?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:15","pubTimestamp":1734336919,"startTime":"0","endTime":"0","summary":"12月16日, 再鼎医药股价涨0.24%，报收20.60元，成交金额3922万元，换手率0.18%，振幅3.41%，量比1.10。再鼎医药今日主力资金净流入106万元，连续3日净流入，上一交易日主力净流入17万元，今日环比增加523.53%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为58.82%，平均涨幅为5.59%。该股近5个交易日下跌8.00%，主力资金累计净流入95万元；近20日主力资金累计净流入8356万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161531a1f2794e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161531a1f2794e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1588","BK1161","LU2488822045.USD","09688"],"gpt_icon":0},{"id":"2490338576","title":"再鼎医药下跌2.1%，报26.59美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490338576","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490338576?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:28","pubTimestamp":1734017333,"startTime":"0","endTime":"0","summary":"12月12日，再鼎医药(ZLAB)盘中下跌2.1%，截至23:28，报26.59美元/股，成交198.01万美元。财务数据显示，截至2024年09月30日，再鼎医药收入总额2.9亿美元，同比增长44.32%；归母净利润-1.75亿美元，同比增长26.66%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/12232846338450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["ZLAB","BK4588","BK4139","09688","BK4548","BK4585","BK1574","LU2488822045.USD","BK1161","BK4531","BK1588","BK4526"],"gpt_icon":0},{"id":"1140009614","title":"异动解读 | 再鼎医药盘中大跌5.54% 或因资金流出加剧导致股价下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1140009614","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140009614?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:45","pubTimestamp":1733982313,"startTime":"0","endTime":"0","summary":"再鼎医药(ZLAB)股价今日盘中出现大幅下挫,引发市场广泛关注。\n\n数据显示,再鼎医药盘中股价一度下跌5.54%,报20.55港元。与此同时,该股资金流出1256.42万港元,远超流入1114.19万港元。\n\n分析人士指出,再鼎医药盘中股价大跌或与资金流出严重有关。尽管公司最新财报显示营收等数据尚可,但大量资金出逃无疑对股价造成了沉重打击。另外,该股换手率较低,仅有0.12%,说明投资者观望情绪浓厚。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 再鼎医药盘中大跌5.54% 或因资金流出加剧导致股价下挫","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09688"],"gpt_icon":0},{"id":"2490821679","title":"再鼎医药(09688)下跌5.08%，报20.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490821679","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490821679?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:14","pubTimestamp":1733980448,"startTime":"0","endTime":"0","summary":"12月12日，再鼎医药(09688)盘中下跌5.08%，截至13:14，报20.55元/股，成交2613.37万元。再鼎医药有限公司主要业务是研发和销售针对肿瘤、自身免疫性疾病、感染性疾病和中枢神经系统疾病的创新药物，以满足全球患者的医疗需求。关键经营数据方面，公司以其强大的研发能力和全球化运营策略，致力于成为全球领先的生物制药公司。截至2024年三季报，再鼎医药营业总收入20.32亿元、净利润-12.29亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/12131446304908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK4526","BK1161","ZLAB","LU2488822045.USD","BK4585","BK4139","09688","BK4531","BK1588","BK4548","BK4588"],"gpt_icon":0},{"id":"2490212628","title":"再鼎医药盘中异动 下午盘急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490212628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490212628?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:14","pubTimestamp":1733980448,"startTime":"0","endTime":"0","summary":"2024年12月12日下午盘13时14分，再鼎医药股票出现波动，股价急速下挫5.08%。截至发稿，该股报20.550港元/股，成交量124.978万股，换手率0.12%，振幅4.16%。再鼎医药股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，思路迪医药股份、晶泰控股-P、北海康成-B涨幅较大，振幅较大的相关个股有思路迪医药股份、晶泰控股-P、帝王国际投资，振幅分别为38.70%、19.44%、18.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212131408984b7e08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212131408984b7e08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","LU2488822045.USD","09688","BK1588"],"gpt_icon":0},{"id":"2490868245","title":"再鼎医药下跌2.02%，报27.17美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868245","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490868245?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:34","pubTimestamp":1733927694,"startTime":"0","endTime":"0","summary":"12月11日，再鼎医药(ZLAB)开盘下跌2.02%，截至22:34，报27.17美元/股，成交21.16万美元。财务数据显示，截至2024年09月30日，再鼎医药收入总额2.9亿美元，同比增长44.32%；归母净利润-1.75亿美元，同比增长26.66%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/11223446284914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4585","BK4139","BK4548","BK1588","BK4526","BK4588","LU2488822045.USD","ZLAB","BK4531","BK1161","BK1574","09688"],"gpt_icon":0},{"id":"2490722940","title":"南向资金12月10日净卖出再鼎医药2.80万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490722940","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490722940?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:30","pubTimestamp":1733880623,"startTime":"0","endTime":"0","summary":"12月10日，南向资金减持再鼎医药2.80万股连续3日减持。截止当日收盘，港股通共持有再鼎医药10603.05万股，占流通股9.76%。港股通减持金额前五个股分别为美团-W、小米集团-W、理想汽车-W、药明生物、同程旅行。再鼎医药近5个交易日下跌6.02%，港股通累计增持11.92万股；近20个交易日下跌10.63%，港股通累计增持2193.83万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211093303ab6e1dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211093303ab6e1dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","09688","BK4588","BK4585","ZLAB","BK4548","BK4526","BK4531"],"gpt_icon":0},{"id":"2489523042","title":"再鼎医药上涨2.11%，报28.59美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489523042","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489523042?lang=zh_cn&edition=full","pubTime":"2024-12-07 00:00","pubTimestamp":1733500805,"startTime":"0","endTime":"0","summary":"12月7日，再鼎医药(ZLAB)盘中上涨2.11%，截至00:00，报28.59美元/股，成交229.25万美元。财务数据显示，截至2024年09月30日，再鼎医药收入总额2.9亿美元，同比增长44.32%；归母净利润-1.75亿美元，同比增长26.66%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/07000046125723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4585","BK4139","BK4548","BK1588","BK4526","BK4588","LU2488822045.USD","ZLAB","BK4531","BK1161","BK1574","09688"],"gpt_icon":0},{"id":"2489177872","title":"港股生物医药股走弱，再鼎医药跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489177872","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489177872?lang=zh_cn&edition=full","pubTime":"2024-12-05 10:03","pubTimestamp":1733364221,"startTime":"0","endTime":"0","summary":"每经AI快讯，12月5日，港股生物医药股走弱，再鼎医药跌超7%，云顶新耀-B跌超5%，康诺亚-B和药明合联跌超3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412053259991619.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412053259991619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK4548","ZLAB","BK4526","LU2488822045.USD","BK4585","BK1588","YANG","BK1161","07226","BK4139","HSCEI","BK4588","BK4531","09688","HSTECH"],"gpt_icon":0},{"id":"2489717131","title":"港股生物医药股集体下跌，再鼎医药(09688.HK)跌超7%，百济神州(06160.HK)、药明合联(02268.HK)跌超2%，药明康德(02359.","url":"https://stock-news.laohu8.com/highlight/detail?id=2489717131","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489717131?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:53","pubTimestamp":1733363616,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688235","BK1500","BK4139","LU1046422090.SGD","HSCEI","BGNE","BK1576","HSTECH","LU1969619763.USD","LU1997245094.SGD","603259","BK4548","02359","161726","07226","BK0239","LU0307460666.USD","SG9999014674.SGD","BK4535","LU0456842615.SGD","BK1574","09688","BK1161","BK1588","LU0052750758.USD","LU2045819591.USD","BK1141","LU2125910500.SGD","BK4531","LU0588546209.SGD","YANG","02268","BK4504","ZLAB","BK4588","399441","BK1583","LU2242644610.SGD","BK0216","BK4585","LU0708995583.HKD","LU2488822045.USD","LU0320764599.SGD","06160","BK4526","LU2328871848.SGD","LU1997245177.USD","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":0.0024},{"period":"1month","weight":-0.0072},{"period":"3month","weight":0.2515},{"period":"6month","weight":0.4993},{"period":"1year","weight":-0.0072},{"period":"ytd","weight":-0.0419}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Zai Lab Ltd是一家主要从事生物制药的控股公司该公司致力于发现或许可、开发和商业化专有疗法，以解决中国市场中大量未满足医疗需求的领域，包括肿瘤学、自身免疫和传染病。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物。其中包括Niraparib（ZL-2306）、ZL-2103和ZL-1101等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.016509},{"month":2,"riseRate":0.5,"avgChangeRate":-0.001648},{"month":3,"riseRate":0,"avgChangeRate":-0.143693},{"month":4,"riseRate":0.75,"avgChangeRate":0.076104},{"month":5,"riseRate":0.5,"avgChangeRate":-0.025575},{"month":6,"riseRate":0.25,"avgChangeRate":-0.052584},{"month":7,"riseRate":0.75,"avgChangeRate":0.064885},{"month":8,"riseRate":0.75,"avgChangeRate":0.004625},{"month":9,"riseRate":0.25,"avgChangeRate":-0.078066},{"month":10,"riseRate":0.6,"avgChangeRate":-0.01228},{"month":11,"riseRate":0.6,"avgChangeRate":0.099288},{"month":12,"riseRate":0.4,"avgChangeRate":-0.004617}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}